Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» metastatic non-small cell lung cancer
metastatic non-small cell lung cancer
Sandoz launches oncology generic gefitinib in 13 EU countries
Pharmaceutical Business Review
Wed, 07/3/19 - 09:57 am
Sandoz
Novartis
generics
gefitinib
metastatic non-small cell lung cancer
Lilly's combo treatment meets main goal in lung cancer late-stage study
Yahoo/Reuters
Tue, 03/12/19 - 10:12 am
Eli Lilly
Cyramza
clinical trials
metastatic non-small cell lung cancer
Roche
erlotinib
Merck's Keytruda faces delay in first-line approval decision
Biopharma Dive
Fri, 12/21/18 - 10:39 pm
FDA
Keytruda
Merck
metastatic non-small cell lung cancer
FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications
CP Wire
Tue, 05/29/18 - 10:37 am
Pfizer
Xalkori
metastatic non-small cell lung cancer
FDA
breakthrough therapies
anaplastic large-cell lymphoma
EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer
CP Wire
Thu, 05/3/18 - 11:16 am
Bristol-Myers Squibb
Opdivo
Yervoy
metastatic non-small cell lung cancer
EMA
Europe
Merck's stock surges after positive Keytruda trial results
Marketwatch
Mon, 04/9/18 - 09:32 am
Merck
Keytruda
clinical trials
metastatic non-small cell lung cancer
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
CP Wire
Fri, 04/6/18 - 12:00 am
metastatic non-small cell lung cancer
Altor Bioscience
ALT-803
Opdivo
Bristol-Myers Squibb
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Motley Fool
Thu, 03/15/18 - 09:55 am
cancer
oncology
Pfizer
Ibrance
breast cancer
Xtandi
prostate cancer
Bavencio
bladder cancer
Merkel cell carcinoma
lorlatinib
metastatic non-small cell lung cancer
talazoparib
metastatic breast cancer
Pfizer wins a “breakthrough” title for ALK/ROS1 contender lorlatinib after hustling into PhIII
Endpoints
Thu, 04/27/17 - 05:49 pm
Pfizer
breakthrough status
lorlatinib
metastatic non-small cell lung cancer
Novartis' Lung Cancer Drug Combo Gets EU Nod
Investopedia
Mon, 04/3/17 - 09:19 am
Novartis
Europe
metastatic non-small cell lung cancer
Tafinlar
Mekinist
Merck's Keytruda Approved for Lung Cancer in EU
Investopedia
Wed, 02/1/17 - 05:27 pm
Merck
Keytruda
Europe
metastatic non-small cell lung cancer
KEYTRUDA® (pembrolizumab) Demonstrated Improved Health-Related Quality of Life Compared to Chemotherapy in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
Yahoo
Wed, 12/7/16 - 10:26 am
Keytruda
Merck
metastatic non-small cell lung cancer
FDA approves Merck's lung cancer drug as first-line treatment
Yahoo/Reuters
Mon, 10/24/16 - 11:56 pm
FDA
Merck
Keytruda
metastatic non-small cell lung cancer
Bristol-Myers’s Drug Combination Boosts Lung Cancer Benefit
Bloomberg
Sat, 06/4/16 - 06:23 pm
Bristol-Myers Squibb
Yervoy
Opdivo
metastatic non-small cell lung cancer
FDA accepts new Keytruda data, opening door for wider indication
BioPharma Dive
Wed, 03/9/16 - 03:38 pm
FDA
Keytruda
Merck
metastatic non-small cell lung cancer
AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study
Fierce Biotech
Tue, 02/9/16 - 09:00 am
AstraZeneca
durvalumab
tremelimumab
metastatic non-small cell lung cancer
Pages
« first
‹ previous
1
2